Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 13/20 | 0.43 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.41 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.41 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.41 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | BCR | P11274 | 1/20 | 0.38 |
| ▸ | BRAF | P15056 | 1/20 | 0.38 |
| ▸ | SRC | P12931 | 5/20 | 0.36 |
| ▸ | PIK3C2B | O00750 | 1/20 | 0.36 |
| ▸ | YES1 | P07947 | 1/20 | 0.36 |
| ▸ | FGR | P09769 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22504998 | 0.93 | PIK3CD (0.43) | PIK3CDPIK3R1PIK3CGCSNK1EABL1 | |
| SCHEMBL29641552 | 0.93 | PIK3CD (0.43) | PIK3CDPIK3R1PIK3CGCSNK1EABL1 | |
| SCHEMBL22498344 | 0.88 | PIK3CD (0.46) | PIK3CDPIK3R1PIK3CGCSNK1EABL1 | |
| SCHEMBL29641562 | 0.88 | PIK3CD (0.46) | PIK3CDPIK3R1PIK3CGCSNK1EABL1 | |
| SCHEMBL24494752 | 0.87 | MAP4K4 (0.44) | PIK3CDPIK3R1PIK3CGCSNK1EABL1 | |
| SCHEMBL24494700 | 0.83 | PIK3CD (0.48) | PIK3CDPIK3R1PIK3CGCSNK1EABL1 | |
| SCHEMBL21337756 | 0.81 | PIK3CD (0.44) | PIK3CDPIK3CGABL1BCRBRAF | |
| SCHEMBL22504999 | 0.80 | MAP4K4 (0.43) | PIK3CDPIK3R1PIK3CGCSNK1EABL1 | |
| SCHEMBL29641585 | 0.80 | MAP4K4 (0.43) | PIK3CDPIK3R1PIK3CGCSNK1EABL1 | |
| SCHEMBL16783593 | 0.80 | PIK3CD (0.56) | PIK3CDPIK3CGABL1SRCPIK3C2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220175784-A1 | ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS | CHIESI FARMACEUTICI S.P.A. (IT) | 2022-06-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220175784-A1 | ISOCHROMENE DERIVATIVES AS PHOSPHOINOSITIDE 3-KINASES INHIBITORS | PIKFYVE, PDPK1, PIK3R5 | PIK3CD 5/4885PIK3R1 19/4885PIK3CG 13/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.